Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Amgen
(NQ:
AMGN
)
377.00
-8.70 (-2.26%)
Streaming Delayed Price
Updated: 4:00 PM EST, Mar 3, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,710,557
Open
377.97
Bid (Size)
377.00 (40)
Ask (Size)
380.00 (200)
Prev. Close
385.70
Today's Range
372.71 - 381.74
52wk Range
261.43 - 391.29
Shares Outstanding
538,800,000
Dividend Yield
2.67%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
IBRX Stock Extends Rally To Day 3: Founder Drops ‘Prelude’ To 2025 Earnings, Slams Bristol Myers, Amgen Cancer Playbook
↗
March 03, 2026
The founder criticized traditional chemotherapy approaches from Amgen and Bristol Myers and hyped up the mechanism behind Anktiva.
Via
Stocktwits
Topics
Artificial Intelligence
2 Profitable Stocks with Solid Fundamentals and 1 Facing Headwinds
March 02, 2026
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
Via
StockStory
Performance
YTD
+15.1%
+15.1%
1 Month
+9.4%
+9.4%
3 Month
+11.4%
+11.4%
6 Month
+31.4%
+31.4%
1 Year
+21.3%
+21.3%
More News
Read More
A Couple's Financial Manifesto, Revisited
↗
March 02, 2026
Via
The Motley Fool
Topics
Stocks
Amgen CEO Teases 2026 As ‘Springboard Year’ After 14 Blockbusters And 18 Record Products
↗
February 04, 2026
Via
Stocktwits
Amgen Inc (NASDAQ:AMGN) Beats Q4 2025 Estimates and Provides Strong 2026 Revenue Guidance
↗
February 03, 2026
Via
Chartmill
The Valuation Reset: A Deep-Dive into Novo Nordisk (NVO) in 2026
February 27, 2026
Via
Finterra
Topics
Economy
Intellectual Property
Novo Nordisk Shares Tumble 15.1% After CagriSema Fails to Topple Eli Lilly in Head-to-Head Trial
February 23, 2026
Via
MarketMinute
Eli Lilly Surges as Novo Nordisk’s "CagriSema" Stumbles in High-Stakes Obesity Head-to-Head
February 23, 2026
Via
MarketMinute
Novo Nordisk Shares Plunge 13% as Next-Gen Weight Loss Drug CagriSema Fails to Topple Eli Lilly in Landmark Trial
February 23, 2026
Via
MarketMinute
Topics
Earnings
1 Unpopular Stock That Deserves a Second Chance and 2 We Turn Down
February 22, 2026
Via
StockStory
1 Momentum Stock to Research Further and 2 We Avoid
February 18, 2026
Via
StockStory
The Trillion-Dollar Pharmaceutical Giant: Eli Lilly Makes History as Weight-Loss Revolution Drives Unprecedented Growth
February 17, 2026
Via
MarketMinute
Topics
Earnings
Economy
Gilead Sciences and the 2026 Biotech Resurgence: A Leader in the Great Rotation
February 13, 2026
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Government
1 Large-Cap Stock Worth Your Attention and 2 We Avoid
February 12, 2026
Via
StockStory
The 5 Most Interesting Analyst Questions From Amgen’s Q4 Earnings Call
February 10, 2026
Via
StockStory
Topics
Earnings
The Great GLP-1 Divergence: Eli Lilly Surges Toward Trillion-Dollar Dominance as Novo Nordisk Falters on U.S. Price Cuts
February 05, 2026
Via
MarketMinute
Topics
Earnings
Economy
Trump Administration To Launch TrumpRx Platform For Discounted Drugs Later On Thursday: Reports
↗
February 05, 2026
Via
Stocktwits
Topics
Economy
Government
World Trade
Healthcare Titans Propel Dow to Record Highs as GLP-1 Sales Spark Major Market Rotation
February 05, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Earnings
Intellectual Property
These 2 Companies Could Soon Join the Weight Loss Market: Are They Buys?
↗
February 05, 2026
Via
The Motley Fool
Topics
Intellectual Property
The $1 Trillion Apothecary: A Deep-Dive Research Report on Eli Lilly (LLY)
February 05, 2026
Via
Finterra
Topics
Earnings
Economy
Intellectual Property
Why Is Amgen Stock Falling Premarket?
↗
February 05, 2026
Via
Stocktwits
Explore the top gainers and losers within the S&P500 index in today's session.
↗
February 04, 2026
Via
Chartmill
Wednesday's session: top gainers and losers in the S&P500 index
↗
February 04, 2026
Via
Chartmill
AMGN Q4 Deep Dive: Product Portfolio Expansion and Pipeline Progress Drive Outlook
February 04, 2026
Via
StockStory
Amgen (AMGN) Q4 2025 Earnings Call Transcript
↗
February 03, 2026
Via
The Motley Fool
Topics
Earnings
Frequently Asked Questions
Is Amgen publicly traded?
Yes, Amgen is publicly traded.
What exchange does Amgen trade on?
Amgen trades on the Nasdaq Stock Market
What is the ticker symbol for Amgen?
The ticker symbol for Amgen is AMGN on the Nasdaq Stock Market
What is the current price of Amgen?
The current price of Amgen is 377.00
When was Amgen last traded?
The last trade of Amgen was at 03/03/26 04:00 PM ET
What is the market capitalization of Amgen?
The market capitalization of Amgen is 203.13B
How many shares of Amgen are outstanding?
Amgen has 203B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.